Left ventricular aneurysm risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{MehdiP}} | {{CMG}};{{AE}}{{MehdiP}} | ||
==Overview== | ==Overview== | ||
The common risk factors for developing LV aneurysm include [[ST elevation myocardial infarction|ST elevation MI]], [[hypertrophic cardiomyopathy]] (HCM), [[dilated cardiomyopathy]] (DCM), advanced age and [[hypertension]]. | The common risk factors for developing LV aneurysm include [[ST elevation myocardial infarction|ST elevation MI]], [[hypertrophic cardiomyopathy]] (HCM), [[dilated cardiomyopathy]] (DCM), advanced age, and [[hypertension]]. | ||
==Risk Factors== | ==Risk Factors== | ||
The most potent risk factor for development of the LV aneurysm is '''[[ST elevation myocardial infarction|ST elevation MI]]'''. Other risk factors include:<ref name="pmid19145116">{{cite journal |vauthors=Napodano M, Tarantini G, Ramondo A, Cacciavillani L, Corbetti F, Marra MP, Fraccaro C, Peluso D, Razzolini R, Iliceto S |title=Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction |journal=J Cardiovasc Med (Hagerstown) |volume=10 |issue=1 |pages=44–50 |year=2009 |pmid=19145116 |doi=10.2459/JCM.0b013e32831967b2 |url=}}</ref><ref name="pmid18809796">{{cite journal |vauthors=Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ |title=Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy |journal=Circulation |volume=118 |issue=15 |pages=1541–9 |year=2008 |pmid=18809796 |doi=10.1161/CIRCULATIONAHA.108.781401 |url=}}</ref><ref name="pmid4812079">{{cite journal |vauthors=Bulkley BH, Roberts WC |title=Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm |journal=Am. J. Med. |volume=56 |issue=2 |pages=244–50 |year=1974 |pmid=4812079 |doi= |url=}}</ref><ref name="pmid5659397">{{cite journal |vauthors=Mourdjinis A, Olsen E, Raphael MJ, Mounsey JP |title=Clinical diagnosis and prognosis of ventricular aneurysm |journal=Br Heart J |volume=30 |issue=4 |pages=497–513 |year=1968 |pmid=5659397 |pmc=487659 |doi= |url=}}</ref> | The most potent risk factor for the development of the LV aneurysm is '''[[ST elevation myocardial infarction|ST elevation MI]]'''. Other risk factors include:<ref name="pmid19145116">{{cite journal |vauthors=Napodano M, Tarantini G, Ramondo A, Cacciavillani L, Corbetti F, Marra MP, Fraccaro C, Peluso D, Razzolini R, Iliceto S |title=Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction |journal=J Cardiovasc Med (Hagerstown) |volume=10 |issue=1 |pages=44–50 |year=2009 |pmid=19145116 |doi=10.2459/JCM.0b013e32831967b2 |url=}}</ref><ref name="pmid18809796">{{cite journal |vauthors=Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ |title=Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy |journal=Circulation |volume=118 |issue=15 |pages=1541–9 |year=2008 |pmid=18809796 |doi=10.1161/CIRCULATIONAHA.108.781401 |url=}}</ref><ref name="pmid4812079">{{cite journal |vauthors=Bulkley BH, Roberts WC |title=Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm |journal=Am. J. Med. |volume=56 |issue=2 |pages=244–50 |year=1974 |pmid=4812079 |doi= |url=}}</ref><ref name="pmid5659397">{{cite journal |vauthors=Mourdjinis A, Olsen E, Raphael MJ, Mounsey JP |title=Clinical diagnosis and prognosis of ventricular aneurysm |journal=Br Heart J |volume=30 |issue=4 |pages=497–513 |year=1968 |pmid=5659397 |pmc=487659 |doi= |url=}}</ref> | ||
*[[Hypertrophic cardiomyopathy]] (HCM) | *[[Hypertrophic cardiomyopathy]] (HCM) | ||
*[[Dilated cardiomyopathy]] (DCM) | *[[Dilated cardiomyopathy]] (DCM) | ||
Latest revision as of 03:59, 9 April 2017
|
Left ventricular aneurysm Microchapters |
|
Differentiating Left ventricular aneurysm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Left ventricular aneurysm risk factors On the Web |
|
American Roentgen Ray Society Images of Left ventricular aneurysm risk factors |
|
Risk calculators and risk factors for Left ventricular aneurysm risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
The common risk factors for developing LV aneurysm include ST elevation MI, hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), advanced age, and hypertension.
Risk Factors
The most potent risk factor for the development of the LV aneurysm is ST elevation MI. Other risk factors include:[1][2][3][4]
- Hypertrophic cardiomyopathy (HCM)
- Dilated cardiomyopathy (DCM)
- Advanced age
- Hypertension
- Use of corticosteroids
References
- ↑ Napodano M, Tarantini G, Ramondo A, Cacciavillani L, Corbetti F, Marra MP, Fraccaro C, Peluso D, Razzolini R, Iliceto S (2009). "Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction". J Cardiovasc Med (Hagerstown). 10 (1): 44–50. doi:10.2459/JCM.0b013e32831967b2. PMID 19145116.
- ↑ Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ (2008). "Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy". Circulation. 118 (15): 1541–9. doi:10.1161/CIRCULATIONAHA.108.781401. PMID 18809796.
- ↑ Bulkley BH, Roberts WC (1974). "Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm". Am. J. Med. 56 (2): 244–50. PMID 4812079.
- ↑ Mourdjinis A, Olsen E, Raphael MJ, Mounsey JP (1968). "Clinical diagnosis and prognosis of ventricular aneurysm". Br Heart J. 30 (4): 497–513. PMC 487659. PMID 5659397.